GSK plc (LON:GSK - Get Free Report) insider Wendy Becker purchased 536 shares of GSK stock in a transaction on Thursday, March 20th. The shares were acquired at an average cost of GBX 1,515 ($19.56) per share, for a total transaction of £8,120.40 ($10,484.70).
GSK Stock Down 0.1 %
GSK opened at GBX 1,509 ($19.48) on Friday. The stock has a market capitalization of £61.23 billion, a price-to-earnings ratio of 24.38, a P/E/G ratio of 1.24 and a beta of 0.31. GSK plc has a 1-year low of GBX 1,282.50 ($16.56) and a 1-year high of GBX 1,823.50 ($23.54). The business has a 50 day moving average of GBX 1,441.42 and a 200-day moving average of GBX 1,439. The company has a current ratio of 0.81, a quick ratio of 0.73 and a debt-to-equity ratio of 114.64.
GSK (LON:GSK - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported GBX 23.20 ($0.30) earnings per share (EPS) for the quarter. GSK had a return on equity of 18.08% and a net margin of 8.02%. As a group, sell-side analysts anticipate that GSK plc will post 175.980975 earnings per share for the current year.
Analysts Set New Price Targets
GSK has been the subject of several recent research reports. Berenberg Bank lowered their target price on shares of GSK from GBX 1,820 ($23.50) to GBX 1,600 ($20.66) and set a "buy" rating for the company in a research note on Friday, November 29th. JPMorgan Chase & Co. reaffirmed an "underweight" rating on shares of GSK in a report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, GSK has a consensus rating of "Moderate Buy" and an average target price of GBX 1,805.83 ($23.32).
View Our Latest Stock Analysis on GSK
GSK Company Profile
(
Get Free Report)
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
